GOLDENWELL BIOTECH, INC. (GWLL) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2024 | -$47.2K | -156.1% |
| 2023 | $84.3K | -58.2% |
| 2022 | $201.6K | -33.2% |
| 2021 | $301.7K | +21.4% |
| 2020 | $248.6K | +0.8% |
| 2019 | $246.6K | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2024 | -$47.2K | -156.1% |
| 2023 | $84.3K | -58.2% |
| 2022 | $201.6K | -33.2% |
| 2021 | $301.7K | +21.4% |
| 2020 | $248.6K | +0.8% |
| 2019 | $246.6K | — |